Diagnostic accuracy of fractional exhaled nitric oxide in predicting cough variant asthma and eosinophilic bronchitis in adult patients with chronic cough: A systematic review and meta-analysis
Cough is an important reflex we need to remove irritants from the airways, but for many people, a hypersensitive cough reflex can negatively affect quality of life. A major trigger of chronic cough is airway inflammation from immune cells including type 2 helper T-cells (T H 2), but conventional tests required for diagnosis are technically challenging and often require specialist expertise. Fortunately, measurement of the fractional exhaled nitric oxide (FENO), a potential marker of T H 2 airway inflammation, has become much more common in allergy and pulmonary practices. In this month’s issue of JACI, Song and colleagues review the literature on the use of FENO to diagnose Cough-Variant Asthma (CVA) and Eosinophilic Bronchitis (EB), two major causes of T H 2-mediated chronic cough ( J Allergy Clin Immunol 2017; 140(3): 701-709 ). They looked at thousands of articles from multiple databases in order to answer the question “What is the diagnostic accuracy of FENO for CV...